Post-approval studies (Phase 4)Study completedNCT02187250
What this trial is testing
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 45